nodes	percent_of_prediction	percent_of_DWPC	metapath
Pefloxacin—TOP2A—breast cancer	0.42	1	CbGaD
Pefloxacin—TOP2A—Idarubicin—breast cancer	0.208	0.406	CbGbCtD
Pefloxacin—TOP2A—Mitoxantrone—breast cancer	0.0895	0.174	CbGbCtD
Pefloxacin—TOP2A—Epirubicin—breast cancer	0.0725	0.141	CbGbCtD
Pefloxacin—CYP1A2—Anastrozole—breast cancer	0.042	0.0819	CbGbCtD
Pefloxacin—TOP2A—Doxorubicin—breast cancer	0.0385	0.075	CbGbCtD
Pefloxacin—CYP1A2—Toremifene—breast cancer	0.0384	0.0749	CbGbCtD
Pefloxacin—CYP1A2—Tamoxifen—breast cancer	0.014	0.0273	CbGbCtD
Pefloxacin—CYP1A2—Fluorouracil—breast cancer	0.0103	0.0202	CbGbCtD
Pefloxacin—Enoxacin—TOP2A—breast cancer	0.000524	0.149	CrCbGaD
Pefloxacin—TOP2A—Docetaxel—Paclitaxel—breast cancer	0.000475	0.12	CbGdCrCtD
Pefloxacin—TOP2A—Gefitinib—Lapatinib—breast cancer	0.000466	0.118	CbGdCrCtD
Pefloxacin—Ofloxacin—ABCC1—breast cancer	0.00044	0.125	CrCbGaD
Pefloxacin—Lomefloxacin—TOP2A—breast cancer	0.000397	0.113	CrCbGaD
Pefloxacin—Levofloxacin—TOP2A—breast cancer	0.000339	0.0964	CrCbGaD
Pefloxacin—Ofloxacin—TOP2A—breast cancer	0.000339	0.0964	CrCbGaD
Pefloxacin—TOP2A—Topotecan—Irinotecan—breast cancer	0.000338	0.0857	CbGdCrCtD
Pefloxacin—Ciprofloxacin—TOP2A—breast cancer	0.000328	0.0931	CrCbGaD
Pefloxacin—TOP2A—Vindesine—Vinorelbine—breast cancer	0.000302	0.0766	CbGdCrCtD
Pefloxacin—Norfloxacin—TOP2A—breast cancer	0.000275	0.0782	CrCbGaD
Pefloxacin—TOP2A—Vindesine—Vinblastine—breast cancer	0.000242	0.0613	CbGdCrCtD
Pefloxacin—TOP2A—Paclitaxel—Docetaxel—breast cancer	0.000237	0.0601	CbGdCrCtD
Pefloxacin—Gatifloxacin—ALB—breast cancer	0.00022	0.0625	CrCbGaD
Pefloxacin—TOP2A—Daunorubicin—Idarubicin—breast cancer	0.000173	0.0439	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Idarubicin—breast cancer	0.000173	0.0439	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Idarubicin—breast cancer	0.000173	0.0439	CbGdCrCtD
Pefloxacin—TOP2A—Vincristine—Vinorelbine—breast cancer	0.000163	0.0413	CbGdCrCtD
Pefloxacin—TOP2A—Vinorelbine—Vinblastine—breast cancer	0.000153	0.0387	CbGdCrCtD
Pefloxacin—Norfloxacin—CYP1A1—breast cancer	0.000147	0.0418	CrCbGaD
Pefloxacin—TOP2A—Vinblastine—Vinorelbine—breast cancer	0.000131	0.0333	CbGdCrCtD
Pefloxacin—TOP2A—Vincristine—Vinblastine—breast cancer	0.00013	0.0331	CbGdCrCtD
Pefloxacin—Levofloxacin—CYP3A4—breast cancer	0.000116	0.0329	CrCbGaD
Pefloxacin—Ciprofloxacin—CYP3A4—breast cancer	0.000112	0.0318	CrCbGaD
Pefloxacin—TOP2A—Methyltestosterone—Fluoxymesterone—breast cancer	0.00011	0.0278	CbGdCrCtD
Pefloxacin—Levofloxacin—ABCB1—breast cancer	9.65e-05	0.0274	CrCbGaD
Pefloxacin—Norfloxacin—CYP3A4—breast cancer	9.4e-05	0.0267	CrCbGaD
Pefloxacin—Ciprofloxacin—ABCB1—breast cancer	9.32e-05	0.0265	CrCbGaD
Pefloxacin—TOP2A—Cytarabine—Gemcitabine—breast cancer	8.57e-05	0.0217	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Epirubicin—breast cancer	7.95e-05	0.0201	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Epirubicin—breast cancer	7.95e-05	0.0201	CbGdCrCtD
Pefloxacin—TOP2A—Doxorubicin—Epirubicin—breast cancer	7.95e-05	0.0201	CbGdCrCtD
Pefloxacin—TOP2A—Epirubicin—Doxorubicin—breast cancer	7.35e-05	0.0186	CbGdCrCtD
Pefloxacin—TOP2A—Daunorubicin—Doxorubicin—breast cancer	7.35e-05	0.0186	CbGdCrCtD
Pefloxacin—TOP2A—Idarubicin—Doxorubicin—breast cancer	7.35e-05	0.0186	CbGdCrCtD
Pefloxacin—TOP2A—Norethindrone—Fluoxymesterone—breast cancer	7.16e-05	0.0181	CbGdCrCtD
Pefloxacin—TOP2A—Azacitidine—Gemcitabine—breast cancer	6.14e-05	0.0156	CbGdCrCtD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTA4—breast cancer	5.99e-05	0.00102	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—AURKA—breast cancer	5.93e-05	0.001	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA2—breast cancer	5.92e-05	0.001	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—SULT1A1—breast cancer	5.85e-05	0.000991	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GPX2—breast cancer	5.84e-05	0.00099	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—breast cancer	5.79e-05	0.000982	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	5.79e-05	0.000982	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GPX4—breast cancer	5.77e-05	0.000978	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—SULT1A1—breast cancer	5.77e-05	0.000978	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTA1—breast cancer	5.71e-05	0.000968	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	5.7e-05	0.000967	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	5.68e-05	0.000964	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NAT2—breast cancer	5.65e-05	0.000957	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	5.62e-05	0.000954	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—NAT2—breast cancer	5.57e-05	0.000944	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	5.5e-05	0.000933	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—breast cancer	5.49e-05	0.000931	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CHEK2—breast cancer	5.3e-05	0.000899	CbGpPWpGaD
Pefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—breast cancer	5.26e-05	0.000892	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—COMT—breast cancer	5.21e-05	0.000884	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	5.21e-05	0.000883	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTP1—breast cancer	5.19e-05	0.00088	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—HSP90AA1—breast cancer	5.18e-05	0.000878	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	5.1e-05	0.000866	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	4.98e-05	0.000844	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	4.97e-05	0.000843	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BRCA1—breast cancer	4.97e-05	0.000842	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	4.96e-05	0.000841	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	4.92e-05	0.000834	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—breast cancer	4.86e-05	0.000825	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	4.81e-05	0.000815	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	4.8e-05	0.000813	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—breast cancer	4.78e-05	0.00081	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	4.77e-05	0.00081	CbGpPWpGaD
Pefloxacin—CYP1A2—Phase II conjugation—GSTM1—breast cancer	4.77e-05	0.000808	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—JUN—breast cancer	4.76e-05	0.000807	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—breast cancer	4.71e-05	0.000799	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	4.69e-05	0.000796	CbGpPWpGaD
Pefloxacin—CYP1A2—Tryptophan metabolism—MDM2—breast cancer	4.68e-05	0.000794	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—breast cancer	4.67e-05	0.000791	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—breast cancer	4.65e-05	0.000788	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—PTEN—breast cancer	4.6e-05	0.000781	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—MTR—breast cancer	4.6e-05	0.00078	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—H2AFX—breast cancer	4.6e-05	0.00078	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—E2F1—breast cancer	4.57e-05	0.000775	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—breast cancer	4.51e-05	0.000766	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—HPGDS—breast cancer	4.51e-05	0.000765	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—MAPK8—breast cancer	4.5e-05	0.000764	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BRCA2—breast cancer	4.49e-05	0.000762	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	4.45e-05	0.000754	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTT1—breast cancer	4.38e-05	0.000742	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCNE1—breast cancer	4.35e-05	0.000738	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	4.33e-05	0.000735	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—breast cancer	4.3e-05	0.000729	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—breast cancer	4.28e-05	0.000725	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—breast cancer	4.28e-05	0.000725	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TYMS—breast cancer	4.27e-05	0.000724	CbGpPWpGaD
Pefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—breast cancer	4.22e-05	0.000716	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—breast cancer	4.2e-05	0.000712	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—breast cancer	4.18e-05	0.00071	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP17A1—breast cancer	4.14e-05	0.000703	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—H2AFX—breast cancer	4.11e-05	0.000698	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—PTGS1—breast cancer	4.1e-05	0.000696	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	4.1e-05	0.000695	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP17A1—breast cancer	4.09e-05	0.000693	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—E2F1—breast cancer	4.09e-05	0.000693	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—breast cancer	4.07e-05	0.00069	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP2D6—breast cancer	4.02e-05	0.000682	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	3.99e-05	0.000676	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	3.98e-05	0.000674	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP2D6—breast cancer	3.97e-05	0.000673	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NCOA2—breast cancer	3.95e-05	0.00067	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—breast cancer	3.95e-05	0.000669	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—breast cancer	3.94e-05	0.000668	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	3.9e-05	0.000661	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—BIRC5—breast cancer	3.84e-05	0.000651	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—breast cancer	3.72e-05	0.000632	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TERT—breast cancer	3.72e-05	0.000631	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	3.71e-05	0.00063	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	3.68e-05	0.000624	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	3.65e-05	0.000619	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—breast cancer	3.65e-05	0.000619	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—breast cancer	3.56e-05	0.000603	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP3A4—breast cancer	3.55e-05	0.000602	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK2—breast cancer	3.52e-05	0.000598	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP3A4—breast cancer	3.5e-05	0.000593	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1B1—breast cancer	3.49e-05	0.000591	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	3.48e-05	0.000591	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—breast cancer	3.44e-05	0.000583	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	3.38e-05	0.000574	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—ATM—breast cancer	3.34e-05	0.000567	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDK4—breast cancer	3.33e-05	0.000565	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—NCOA1—breast cancer	3.33e-05	0.000564	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP19A1—breast cancer	3.28e-05	0.000556	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	3.27e-05	0.000555	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	3.27e-05	0.000555	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	3.26e-05	0.000554	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—breast cancer	3.24e-05	0.000549	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	3.23e-05	0.000548	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	3.2e-05	0.000543	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	3.2e-05	0.000543	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	3.16e-05	0.000536	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	3.16e-05	0.000536	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—TP53—breast cancer	3.14e-05	0.000533	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—COMT—breast cancer	3.05e-05	0.000517	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	3.05e-05	0.000517	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	3.05e-05	0.000517	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTP1—breast cancer	3.03e-05	0.000515	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	3.02e-05	0.000513	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—COMT—breast cancer	3.01e-05	0.00051	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	3e-05	0.000508	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	2.99e-05	0.000507	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—RB1—breast cancer	2.9e-05	0.000491	CbGpPWpGaD
Pefloxacin—TOP2A—Circadian rythm related genes—IL6—breast cancer	2.88e-05	0.000488	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—GSTM1—breast cancer	2.79e-05	0.000473	CbGpPWpGaD
Pefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.76e-05	0.000469	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	2.75e-05	0.000466	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	2.74e-05	0.000465	CbGpPWpGaD
Pefloxacin—CYP1A2—Biological oxidations—CYP1A1—breast cancer	2.64e-05	0.000448	CbGpPWpGaD
Pefloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	2.61e-05	0.000442	CbGpPWpGaD
Pefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	2.57e-05	0.000436	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	2.55e-05	0.000432	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—breast cancer	2.52e-05	0.000428	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	2.47e-05	0.000419	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MDM2—breast cancer	2.47e-05	0.000419	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—breast cancer	2.41e-05	0.000408	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—breast cancer	2.33e-05	0.000395	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.27e-05	0.000385	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1B—breast cancer	2.25e-05	0.000382	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.24e-05	0.000381	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.19e-05	0.000372	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CCND1—breast cancer	2.15e-05	0.000365	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SYNJ2—breast cancer	2.13e-05	0.000361	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—CDKN1A—breast cancer	2.08e-05	0.000353	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—breast cancer	1.98e-05	0.000336	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NDUFS3—breast cancer	1.98e-05	0.000335	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—breast cancer	1.93e-05	0.000327	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	1.9e-05	0.000322	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CHST9—breast cancer	1.86e-05	0.000315	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	1.82e-05	0.000308	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MAPK3—breast cancer	1.77e-05	0.000301	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	1.77e-05	0.0003	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—COX11—breast cancer	1.76e-05	0.000299	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	1.73e-05	0.000294	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—MYC—breast cancer	1.73e-05	0.000293	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	1.68e-05	0.000285	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SHMT1—breast cancer	1.61e-05	0.000273	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CDA—breast cancer	1.61e-05	0.000273	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	1.59e-05	0.00027	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.58e-05	0.000267	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC2A5—breast cancer	1.55e-05	0.000263	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLCO1B1—breast cancer	1.55e-05	0.000263	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.52e-05	0.000257	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—APRT—breast cancer	1.5e-05	0.000254	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.47e-05	0.000249	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.46e-05	0.000248	CbGpPWpGaD
Pefloxacin—TOP2A—Cell Cycle—TP53—breast cancer	1.42e-05	0.00024	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.41e-05	0.000239	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ESRRA—breast cancer	1.41e-05	0.000239	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.34e-05	0.000227	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HADHB—breast cancer	1.34e-05	0.000226	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GPI—breast cancer	1.34e-05	0.000226	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.28e-05	0.000217	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.27e-05	0.000216	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.27e-05	0.000216	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.26e-05	0.000214	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ADSL—breast cancer	1.22e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PHGDH—breast cancer	1.22e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—UMPS—breast cancer	1.22e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NME1—breast cancer	1.22e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—FHL2—breast cancer	1.22e-05	0.000207	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPSE—breast cancer	1.2e-05	0.000203	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—BRIP1—breast cancer	1.2e-05	0.000203	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—LDHB—breast cancer	1.2e-05	0.000203	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA3—breast cancer	1.14e-05	0.000193	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HMMR—breast cancer	1.14e-05	0.000193	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCC1—breast cancer	1.14e-05	0.000193	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PPARGC1B—breast cancer	1.1e-05	0.000186	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.07e-05	0.000182	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.07e-05	0.000182	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA4—breast cancer	1.04e-05	0.000176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CA9—breast cancer	1.04e-05	0.000176	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.03e-05	0.000174	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.01e-05	0.000172	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GPX2—breast cancer	1.01e-05	0.000172	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA2—breast cancer	1.01e-05	0.000172	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GPX4—breast cancer	1e-05	0.00017	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SULT1A1—breast cancer	1e-05	0.00017	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTA1—breast cancer	9.76e-06	0.000166	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—IDH1—breast cancer	9.76e-06	0.000166	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NAT2—breast cancer	9.65e-06	0.000164	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.73e-06	0.000148	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MED12—breast cancer	8.47e-06	0.000144	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—DPYD—breast cancer	8.47e-06	0.000144	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALDOA—breast cancer	8.33e-06	0.000141	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA3—breast cancer	8.09e-06	0.000137	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC2A2—breast cancer	8.03e-06	0.000136	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.95e-06	0.000135	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCG2—breast cancer	7.87e-06	0.000133	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CPT1A—breast cancer	7.87e-06	0.000133	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTR—breast cancer	7.87e-06	0.000133	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HPGDS—breast cancer	7.72e-06	0.000131	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HBA1—breast cancer	7.67e-06	0.00013	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTT1—breast cancer	7.49e-06	0.000127	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ACHE—breast cancer	7.49e-06	0.000127	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP17A1—breast cancer	7.09e-06	0.00012	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS1—breast cancer	7.01e-06	0.000119	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ENO1—breast cancer	7.01e-06	0.000119	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.99e-06	0.000119	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.9e-06	0.000117	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP2D6—breast cancer	6.88e-06	0.000117	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA2—breast cancer	6.75e-06	0.000115	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—FASN—breast cancer	6.55e-06	0.000111	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—BCHE—breast cancer	6.52e-06	0.000111	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC5A5—breast cancer	6.44e-06	0.000109	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—SLC2A1—breast cancer	6.22e-06	0.000106	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NQO1—breast cancer	6.22e-06	0.000106	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.09e-06	0.000103	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP3A4—breast cancer	6.07e-06	0.000103	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.04e-06	0.000102	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1B1—breast cancer	5.96e-06	0.000101	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.85e-06	9.92e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOA1—breast cancer	5.69e-06	9.65e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—STK11—breast cancer	5.61e-06	9.51e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP19A1—breast cancer	5.61e-06	9.51e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.26e-06	8.93e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—COMT—breast cancer	5.21e-06	8.84e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTP1—breast cancer	5.19e-06	8.8e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—HMOX1—breast cancer	5.12e-06	8.68e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ITPR1—breast cancer	5.11e-06	8.66e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ABCB1—breast cancer	4.91e-06	8.33e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—TYMS—breast cancer	4.82e-06	8.18e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.77e-06	8.09e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GSTM1—breast cancer	4.77e-06	8.09e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NCOR1—breast cancer	4.77e-06	8.09e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—GPX1—breast cancer	4.57e-06	7.74e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CYP1A1—breast cancer	4.52e-06	7.67e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ERCC2—breast cancer	4.48e-06	7.6e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—MTHFR—breast cancer	4.21e-06	7.15e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—CAV1—breast cancer	3.89e-06	6.59e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.71e-06	6.3e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CG—breast cancer	3.54e-06	6e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CD—breast cancer	3.11e-06	5.28e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—ALB—breast cancer	3.07e-06	5.21e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—NOS3—breast cancer	2.94e-06	4.98e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CB—breast cancer	2.71e-06	4.6e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTGS2—breast cancer	2.69e-06	4.56e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PTEN—breast cancer	2.34e-06	3.98e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—PIK3CA—breast cancer	1.65e-06	2.8e-05	CbGpPWpGaD
Pefloxacin—CYP1A2—Metabolism—AKT1—breast cancer	1.35e-06	2.29e-05	CbGpPWpGaD
